Active not recruiting

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus

I4V-MC-JAIA - ClinicalTrials.gov - NCT03616964

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last up to 62 weeks and may include up to 17 visits.
Email
Active not recruiting

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus

I4V-MC-JAIA - ClinicalTrials.gov - NCT03616964

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last up to 62 weeks and may include up to 17 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months

Participants must have currently active manifestations of lupus

Participants must NOT

Participants must not have severe lupus nephritis

Participants must not have severe central nervous system lupus

Participants must not have or have had another serious medical condition

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

Baricitinib, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

750

Trial Dates

August 2018 - November 2021

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months

Participants must have currently active manifestations of lupus

Participants must NOT

Participants must not have severe lupus nephritis

Participants must not have severe central nervous system lupus

Participants must not have or have had another serious medical condition

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

Baricitinib, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

750

Trial Dates

August 2018 - November 2021

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Lupus (SLE) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?